Effect of the α2-blocker DG-5128 on insulin and somatostatin release from the isolated perfused rat pancreas
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (11) , 1113-1118
- https://doi.org/10.1016/0024-3205(87)90574-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Neural Control of Pancreatic Insulin and Somatostatin SecretionEndocrinology, 1984
- Adrenergic Control of Somatostatin Release*Endocrinology, 1982
- Insulin releasing action of 2-[2-(4,5-dihydro-1H-imadazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128), a new, orally effective hypoglycaemic agentActa Endocrinologica, 1982
- ALPHA-2-ADRENERGIC INHIBITION OF INSULIN-SECRETION VIA INTERFERENCE WITH CYCLIC-AMP GENERATION IN RAT PANCREATIC-ISLETS1982
- Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatographyDiabetes, 1981
- Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreasDiabetes, 1980
- Adrenergic Modulation of Pancreatic A, B, and D CellsJournal of Clinical Investigation, 1979
- Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†Journal of Clinical Endocrinology & Metabolism, 1971
- Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in manJournal of Clinical Investigation, 1971